
Sign up to save your podcasts
Or


Predicting which patients with IBD will develop complications allows for much better medication choices. But how do we go about predicting that risk? Joining Dr. Peter Buch to tackle this topic is Dr. Corey Siegel, Section Chief of Gastroenterology and Hepatology at Dartmouth-Hitchcock Medical Center.
By ReachMD4.7
1818 ratings
Predicting which patients with IBD will develop complications allows for much better medication choices. But how do we go about predicting that risk? Joining Dr. Peter Buch to tackle this topic is Dr. Corey Siegel, Section Chief of Gastroenterology and Hepatology at Dartmouth-Hitchcock Medical Center.

2,058 Listeners

695 Listeners

496 Listeners

69 Listeners

1 Listeners

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

0 Listeners

0 Listeners

2,442 Listeners

3,332 Listeners

56,419 Listeners

1,153 Listeners

513 Listeners

252 Listeners

217 Listeners

13 Listeners

18 Listeners

33 Listeners